Metraipolis › archive › dc_d516a48e9935

Adipiplon — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/Adipiplon
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-07T14:29:19.029Z
SHA-256 of the archived text
498763e5fa94f25178218b0ce8790ea7d07330c7f7ae839491c160923deb804a
Stable URL of this page
https://metraipolis.com/documento/dc_d516a48e9935

How to cite

Adipiplon — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Adipiplon (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_d516a48e9935 (Metraipolis archive dc_d516a48e9935, sha256 498763e5fa94f25178218b0ce8790ea7d07330c7f7ae839491c160923deb804a)
BibTeX
@misc{dcd516a48e9935,
  title = {Adipiplon — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/Adipiplon},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_d516a48e9935; sha256 498763e5fa94f25178218b0ce8790ea7d07330c7f7ae839491c160923deb804a},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Adipiplon. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Adipiplon (developmental code name NG2-73) is an anxiolytic drug developed by Neurogen Corporation. It has similar effects to benzodiazepine drugs, but is structurally distinct and classed as a nonbenzodiazepine anxiolytic. Adipiplon is a subtype-selective GABAA receptor partial agonist, which binds preferentially to the α3 subtype. This is significant as while several previous nonbenzodiazepine drugs have been developed that are selective for α2/3 over the other subtypes, adipiplon is one of the first drugs selected for clinical development which can discriminate between α2 and α3, as well as showing a little affinity for the α1 or α5 subtypes — alpidem is selective for α3 over α2, but still has moderate affinity for α1, whereas adipiplon is highly α3-selective with little affinity for either α1, α2 or α5. Adipiplon was being researched as a potential medication for the treatment of anxiety and insomnia, and in 2008 it was being used in Phase IIb trials. These trials were suspended after significant next-day side effects were discovered.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «Adipiplon» — https://en.wikipedia.org/wiki/Adipiplon
Wikidata Q4682933: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4682933
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Adipiplon?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1382432148, consultata il 2026-11-07T14:25:13.250Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: d19841e264efcd3ed47cadcb2e6d30f38834103642b1886c83facf1546e61b26